Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJardine Math.sr Regulatory News (JAR)

Share Price Information for Jardine Math.sr (JAR)

Share Price is delayed by 15 minutes
Get Live Data
62.50    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: $18.42b
JAR Live PriceLast checked at - London Stock Exchange

Intraday Jardine Math.sr Share Chart

Interim Management Statement

10 Nov 2022 09:40

RNS Number : 9937F
Hongkong Land Hldgs Ltd
10 November 2022
Β 

Announcement

Β 

The following announcement was issued today to a Regulatory Information Service approved by the Financial Conduct Authority in the United Kingdom.

Β 

HONGKONG LAND HOLDINGS LIMITED

Interim Management Statement

Β 

10th November 2022 - Hongkong Land Holdings Limited today issues an Interim Management Statement for the third quarter of 2022.

Β 

The Group's underlying profit in the third quarter was lower than the same period in 2021. Trading continued to be affected by anti-pandemic measures taken across China, with contracted sales in the Development Properties business particularly impacted. The contribution from Investment Properties was broadly unchanged compared to the same period last year.

Β 

In Hong Kong, the Group's Central office portfolio benefitted from its unique positioning, despite an increase in vacancies across the city in the period. Physical vacancy at 30th September 2022 decreased to 5.1%, compared to 5.4% at the end of June 2022. On a committed basis, vacancy was 4.8%. Vacancy for the overall Central Grade A office market was 8.3% at the end of September 2022. Rental reversions continued to be negative in the period, at a level largely in line with the first half of the year. Leasing activity has softened in recent months compared to the first half of 2022, due to global economic headwinds, although the Group has already secured new leases for almost all tenancies expiring in the remainder of the year.

Β 

The Group's LANDMARK retail portfolio in Hong Kong benefitted from marginally better trading conditions in the third quarter of the year, due to a relaxation of social distancing restrictions in the city. This resulted in a decline in temporary rent relief in the period, although the Group continued to provide support to its tenants on a case-by-case basis. Overall performance, however, continues to be negatively impacted by a lack of overseas visitors. Tenant sales were lower than in the same period in 2021. Physical and committed vacancy at 30th September 2022 remained low at 1.4%.

Β 

Leasing sentiment in the Group's office portfolio in Singapore remained healthy, despite a more challenging global economic outlook. Rental reversions were positive in the period. Physical vacancy decreased to 4.0% at 30th September 2022, from 4.7% at the end of June 2022. On a committed basis, vacancy was 0.7%.

Β 

In Development Properties, market sentiment in respect of residential properties on the Chinese mainland remained weak, due to pandemic-related restrictions and an uncertain economic outlook. The Group's attributable interest in contracted sales was US$346 million in the third quarter, compared to US$258 million in the equivalent period in 2021, mainly due to the timing of sales launches. In the nine months to 30th September 2022, the Group's attributable interest in contracted sales was US$765 million, compared to US$1,618 million in the same period last year.

Β 

In Singapore, residential market sentiment remained stable, as sales performance at the Group's existing projects continued to be satisfactory. In October 2022, the Group launched Copen Grand, a 639-unit executive condominium in the Tengah region, which was 73% sold on its launch weekend. The Group's attributable interest in contracted sales in the city was US$56 million in the period, compared to US$88 million in the equivalent period in 2021. In the nine months to 30th September 2022, the Group's attributable interest in contracted sales was US$326 million, compared to US$260 million in the same period last year.Β  It is too early to assess the impact of the cooling measures introduced in September 2022.

Β 

In August 2022, the Group secured a joint venture project in Suzhou to develop and operate a commercial mixed-used site, consisting of a luxury mall and a hotel. The total developable area of the site is 132,600 sq. m. and it is expected to be completed in 2026.

Β 

The Group's full year underlying profits are expected to be significantly lower than the prior year, primarily due to a lower number of planned sales completions and the impact of pandemic-related restrictions on construction activities on the Chinese mainland, which will result in some completions being deferred from the second half of 2022 into 2023.

Β 

The Group's financial position remains strong. Net debt at 30th September 2022 decreased to US$5.8 billion from US$6.1 billion at the end of June 2022. Committed liquidity was US$2.9 billion, compared to US$2.6 billion at the end of June 2022. 55% of the Group's interest rate on debt is at fixed rates.

Β 

Hongkong Land is a major listed property investment, management and development group. The Group owns and manages more than 850,000 sq. m. of prime office and luxury retail property in key Asian cities, principally Hong Kong, Singapore, Beijing and Jakarta. The Group also has a number of high-quality residential, commercial, and mixed-use projects under development in cities across China and Southeast Asia, including a 43% interest in a 1.1 million sq. m. mixed-use project in West Bund, Shanghai. Its subsidiary, MCL Land, is a well-established residential developer in Singapore. Hongkong Land Holdings Limited is incorporated in Bermuda and has a primary listing in the standard segment of the London Stock Exchange, with secondary listings in Bermuda and Singapore. The Group's assets and investments are managed from Hong Kong by Hongkong Land Limited. Hongkong Land is a member of the Jardine Matheson Group.

Β 

- end -

Β 

Β 

For further information, please contact:

Β 

Hongkong Land Limited

Mark Lam

(852) 2842 8211

Gary Leung

(852) 2842 0601

Β 

Brunswick Group Limited

Nan Dong

(852) 9768 8379

Β 

This and other Group announcements can be accessed through the Internet at 'www.hkland.com'.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DOCFZMMMLGNGZZG
Date   Source Headline
8th May 201912:32 pmRNSInterim Management Statement
2nd May 201910:20 amRNSDividend
29th Apr 201910:49 amRNSFirst Quarter 2019 Results of PT Hero
26th Apr 201910:35 amRNSJC&C 2019 First Quarter Financial Statements
24th Apr 201911:09 amRNSPT Astra 2019 First Quarter Financial Statements
18th Apr 201910:57 amRNSDividend
4th Apr 201910:11 amRNSAnnual Financial Report
29th Mar 20199:15 amRNSTotal Voting Rights
27th Mar 20199:12 amRNSCirc re. Scrip Dividend Scheme
26th Mar 20199:14 amRNSDirector/PDMR Shareholding
25th Mar 20199:12 amRNSBlock listing Interim Review
20th Mar 201910:53 amRNSDirector/PDMR Shareholding
7th Mar 20199:12 amRNSDirector/PDMR Shareholding
28th Feb 20199:25 amRNS2018 Preliminary Announcement of Results
28th Feb 20199:23 amRNS2018 Preliminary Announcement of Results
28th Feb 20199:19 amRNSFull Year 2018 Results of PT Hero
28th Feb 20199:18 amRNS2018 PRELIMINARY ANNOUNCEMENT OF RESULTS
28th Feb 20199:06 amRNS2018 PRELIMINARY ANNOUNCEMENT OF RESULTS
28th Feb 20199:06 amRNS2018 Preliminary Announcement of Results
27th Feb 20199:50 amRNSJC&C 2018 Financial Statements
27th Feb 20199:41 amRNSPT Astra Intl TBK - 2018 FY Financial Statements
31st Jan 20199:07 amRNSTotal Voting Rights
30th Jan 20199:15 amRNSNotice of 2018 Final Results
24th Jan 201911:08 amRNSDirector/PDMR Shareholding
8th Jan 201910:18 amRNSDirector/PDMR Shareholding
31st Dec 20187:00 amRNSTotal Voting Rights
20th Dec 201811:32 amRNSDirector Declaration
17th Dec 20187:00 amRNSDF Increases Interest in Rose Pharmacy Inc to 100%
7th Dec 20189:08 amRNSDirectorate Change
30th Nov 20189:16 amRNSTotal Voting Rights
23rd Nov 20189:10 amRNSDF Completes Partnership with Robinsons in Phl
8th Nov 20189:20 amRNSInterim Management Statement
8th Nov 20189:17 amRNSInterim Management Statement
8th Nov 20189:12 amRNSInterim Management Statement
8th Nov 20189:12 amRNSInterim Management Statement
8th Nov 20189:10 amRNSInterim Management Statement
7th Nov 20189:21 amRNS2018 Third Quarter Financial Statements
31st Oct 20189:10 amRNSTotal Voting Rights
30th Oct 201810:02 amRNSNine Months 2018 Results of PT Hero
29th Oct 20187:00 amRNSPT Astra 2018 Third Quarter Financial Statements
24th Oct 201811:31 amRNSDirector/PDMR Shareholding
11th Oct 201811:52 amRNSDirector/PDMR Shareholding
10th Oct 201810:13 amRNSDirector/PDMR Shareholding
5th Oct 201810:35 amRNSAdditional Listing
2nd Oct 201811:04 amRNSForm 8.3 - Jardine Lloyd Thompson Group plc
2nd Oct 20187:00 amRNSDF Increases Interest in Rose Pharmacy Inc to 100%
1st Oct 20187:00 amRNSDirectorate Change
1st Oct 20187:00 amRNSDirectorate Change
1st Oct 20187:00 amRNSDirectorate Change
1st Oct 20187:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.